INNER EAR ORGANOIDS FOR THE STUDY OF HUMAN HEARING AND BALANCE
Dr Jackie Ogier
Passe & Williams Post-Doctoral Research Fellow
Audiology and Speech Pathology
University of Melbourne
RESEARCHER PROFILE (Filmed in Melbourne | August 2024)
Dr Jackie Ogier is an auditory neuroscientist, with a research focus on the molecular biology of hair cells, the specialised sensory receptors in the ear that detect sound and balance. She is a postdoctoral research fellow in the laboratory of A/Prof Bryony Nayagam, supported by a prestigious Passe and Williams foundation fellowship.
Dr Ogier completed her PhD in Neuroscience at the University of Melbourne in 2020, where she investigated the pathogenic mechanisms underlying hearing loss and identified a novel molecular target for preventing aminoglycoside-induced hearing damage. She performed this research at the Murdoch Children’s Research Institute under the guidance of A/Prof Paul Lockhart, A/Prof Bryony Nayagam, and Dr Rachel Burt. During this time, she was President of the Research Students Association and a member of the MCRI Honours and Children’s Campus Graduate Research Training Committees. For her service to discipline, she was recognised with the MCRI Rising Star award in 2017.
Dr Ogier then undertook post-doctoral training at the Sunnybrook Research Institute (University of Toronto) with Prof Alain Dabdoub, where she optimised the collection, dissection, and culture of donated human cochleae for single cell sequencing. She also received The University of Toronto’s Dr Ian Witterick Research Prize in Otolaryngology Head & Neck Surgery for her continued ototoxicity research. Jackie subsequently established a collaboration between the Universities of Toronto and Melbourne to develop an “inner ear in a dish” that will accelerate hearing and balance discovery research.
Dr Ogier’s experience broadly spans the genetics of hearing loss, disease modelling, micro dissection, primary cell culture, stem cell culture, organoids, and proteomics. Overall, she aims to generate knowledge of hearing and vestibular sensory biology.
-
CASE STUDY Next Generation Condom Contraception
Eudaemon Technologies, an early-stage medtech company with a focus on sexual reproductive health, is developing a hydrogel condom to address the need for a better feeling, next generation condom, with the potential to improve user experience and address issues with traditional latex condoms.
“Over 1 million STI’s being diagnosed every day and up to 120 million unplanned pregnancies every year result in a $60 billion health burden across the globe”, says Co-Founder and Executive Director of Operations, Dr Simon Cook.
Formed in 2018, the company focuses on developing tough hydrogels as an alternative to address issues with odour, colour, and taste commonly associated with latex condoms. This technology can be loaded with small molecule drugs for flavours or anti-STI compounds, and was developed in response to a grant from the Bill and Melinda Gates Foundation to address unplanned pregnancies and STIs.
-
Impact of Leukaemia Foundation’s Research Funding into Blood Cancer
Bill Stavreski is the Head of Research at the Leukaemia Foundation who talks about the research impact in recent years. The Foundation itself marks its 25th anniversary in 2025, having funded a wide range of health and medical research since 2000. With a focus on basic science, health services research, treatment, and care, the organisation has invested nearly $90 million (adjusted in current dollars terms) in approximately 370 research grants over the years.
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
